VRNOD
Verano Holdings Corp.
$6.18
-0.35 (-5.36%)
Institutional flow:
-33% holders QoQ
1 Down Day
Indicators
Price
Panels
Event markers
Price & Indicators
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.18
Open$6.40
Day$6.00–6.62
52W$0.48–6.62
Avg vol 30d755K
Short int40K · 1.0d
Short vol27%
Last earningsApr 30, 2026
DataFeb 2021–Jul 2026
Filing10-Q · Apr 30
Equibles Rating
blended score
Overall
Buy
Technical · trend & momentum
Buy
+
Price vs 200-day avg · +297% above
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+297% above
+
Price vs 50-day avg
+140% above
−
RSI (14)
77 · overbought
+
MACD trend
positive
+
52-week position
93% · near high
Sentiment · smart money
Neutral
+
Short interest · 0.01% of float · ▼ -76.0% MoM · 1.0 days cover
◦
Trend (MA cross)
50d $3 › 200d $2 — 50d above 200d
−
Institutional flow
-33% holders QoQ
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.01% of float · ▼ -76.0% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
2 holders — 13F breadth
Fundamentals
Strong
+
Gross margin · 50%, contracting
−
Revenue growth
−6% Y/Y
+
Gross margin
50%, contracting
+
EPS growth
+28% Y/Y
+
Free cash flow
$11.6M
−
Balance sheet
net debt $317.0M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Key facts
Market Cap
$2.26B
Shares
364,381,806
CIK
1848416
CUSIP
92339H101
Website
Visit website
Investor Relations
Investor relations
Up next
Next earnings call
Jul 26, 2026
Est · unconfirmed
· in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Apr 30, 2026
Guidance & track record
Latest guidance
· from the 8-K filed Apr 30, 2026
Capital expenditures
· 2026
$30M – $50M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+297% above
Bullish
Price vs 50-day avg
+140% above
Bullish
RSI (14)
77 · overbought
Bearish
MACD trend
positive
Bullish
52-week position
93% · near high
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $3 › 200d $2 — 50d above 200d
Institutional flow
Distributing
-33% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.01% of float · ▼ -76.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
2 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $0
Now $6 · 93%
52-wk high $7
vs 200-day avg +297%
vs 50-day avg +140%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VRNOD
this stock
Verano Holdings Corp.
|
$2.26B | +390.5% | -6.5% | — | 0.0% |
|
GALDY
Galderma Group AG/ADR
|
$53.33B | +9.7% | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$50.65B | +2.8% | — | — | 0.3% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$41.35B | -7.7% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VRNOD | +16.4% | +415.0% | +410.7% | -5.4% | +390.5% |
| SPY | +1.8% | -1.6% | +7.9% | -1.3% | +9.5% |
| vs SPY | +14.6% | +416.6% | +402.8% | -4.1% | +381.0% |